On-Demand: Practical IP for Life Sciences
The collision of new technologies and patent statutes of a by-gone era have led the Courts of the United States into new and uncharted territories. The Courts are wrestling to apply 1952 statutes to advances in computers, software, biotechnology and genetic medicine, and the fall-out has spread across all technologies. “New” judge-made law has been spawned from “old” established principles. Chemical patent law is no longer cut and dried. Biology has morphed into biotechnology with exciting medical/genetic advances that are denied patent protection by recent judge-made law. Even claims to polymer technology are not immune from the judges’ arm wrestling opinions.
In this complimentary webinar series, the Schwegman bio/chem legal team provide practical tips to companies and universities looking for an understanding of this legal maze. We explore and discuss current views of the law as applied to real situations, point out claim language that was acceptable in the past but now is not, and will suggest possible workarounds. We also apply the “new rules” to prosecution, opinion practice and defending and asserting patents in IPR.